The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Mxra8 is a receptor for multiple arthritogenic alphaviruses
Open accessAbstract
Arthritogenic alphaviruses comprise a group of enveloped RNA viruses that are transmitted to humans by mosquitoes and cause debilitating acute and chronic musculoskeletal disease 1 . The host factors required for alphavirus entry remain poorly characterized 2 . Here we use a genome-wide CRISPR-Cas9-based screen to identify the cell adhesion molecule Mxra8 as an entry mediator for multiple emerging arthritogenic alphaviruses, including chikungunya, Ross River, Mayaro and O'nyong nyong viruses. Gene editing of mouse Mxra8 or human MXRA8 resulted in reduced levels of viral infection of cells and, reciprocally, ectopic expression of these genes resulted in increased infection. Mxra8 bound directly to chikungunya virus particles and enhanced virus attachment and internalization into cells. Consistent with these findings, Mxra8-Fc fusion protein or anti-Mxra8 monoclonal antibodies blocked chikungunya virus infection in multiple cell types, including primary human synovial fibroblasts, osteoblasts, chondrocytes and skeletal muscle cells. Mutagenesis experiments suggest that Mxra8 binds to a surface-exposed region across the A and B domains of chikungunya virus E2 protein, which are a speculated site of attachment. Finally, administration of the Mxra8-Fc protein or anti-Mxra8 blocking antibodies to mice reduced chikungunya and O'nyong nyong virus infection as well as associated foot swelling. Pharmacological targeting of Mxra8 could form a strategy for mitigating infection and disease by multiple arthritogenic alphaviruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“sample sizes were determined based on previous in vivo virus challenge experiments4.”
From LDLRAD3 is a receptor for Venezuelan equine encephalitis virus (2020) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,975
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Li, W., Xu, H., Xiao, T., Cong, L., Love, M. I., Zhang, F., Irizarry, R. A., Liu, J. S., Brown, M., & Liu, X. S. (2014) · Genome Biology · doi:10.1186/s13059-014-0554-4 · Cited by 2,684
RNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098
Genome-scale CRISPR-Cas9 Knockout and Transcriptional Activation Screening
Joung, J., Konermann, S., Gootenberg, J. S., Abudayyeh, O. O., Platt, R. J., Brigham, M. D., Sanjana, N. E., & Zhang, F. (2017) · Nature Protocols · doi:10.1038/nprot.2017.016 · Cited by 1,243
Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography
Voss, J. E., Vaney, M. C., Duquerroy, S., Vonrhein, C., Girard-Blanc, C., Crublet, E., Thompson, A., Bricogne, G., & Rey, F. A. (2010) · Nature · doi:10.1038/nature09555 · Cited by 696
Junction Adhesion Molecule Is a Receptor for Reovirus
Barton, E. S., Forrest, J. C., Connolly, J. L., Chappell, J. D., Liu, Y., Schnell, F. J., Nusrat, A., Parkos, C. A., & Dermody, T. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00231-8 · Cited by 624
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
Oliphant, T., Engle, M. J., Nybakken, G. E., Doane, C., Johnson, S., Huang, L., Gorlatov, S. N., Mehlhop, E., Marri, A., Chung, K. M., et al. (2005) · Nature Medicine · doi:10.1038/nm1240 · Cited by 514
Self-citation
Cited by
Sorted by citations
Bartholomeeusen, K., Daniel, M., LaBeaud, A. D., Gasque, P., Peeling, R. W. W., Stephenson, K. E., Ng, L. F. P., & Ariën, K. K. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00429-2 · Cited by 345
A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
Zhu, Y., Feng, F., Hu, G., Wang, Y., Yin, Y., Zhu, Y., Xü, W., Cai, X., Sun, Z., Han, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21213-4 · Cited by 307
Self-citationA Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development
Cavalcanti, T. Y. V. D. L., Pereira, M. R., de Paula, S. O., & França, R. F. D. O. (2022) · Viruses · doi:10.3390/v14050969 · Cited by 284
Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor
Basore, K., Kim, A. S., Nelson, C. A., Zhang, R., Smith, B. K., Uranga, C., Vang, L., Cheng, M., Gross, M. L., Smith, J. D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.006 · Cited by 209
Self-citationRheumatic manifestations of chikungunya: emerging concepts and interventions
Suhrbier, A. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0276-9 · Cited by 210
Song, H., Zhao, Z., Chai, Y., Jin, X., Li, C., Yuan, F., Liu, S., Gao, Z., Wang, H., Song, J. G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.008 · Cited by 172
LDLRAD3 is a receptor for Venezuelan equine encephalitis virus
Ma, H., Kim, A. S., Kafai, N. M., Earnest, J. T., Shah, A. P., Case, J. B., Basore, K., Gilliland, T. C., Sun, C., Nelson, C. A., et al. (2020) · Nature · doi:10.1038/s41586-020-2915-3 · Cited by 161
Self-citationA versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
Amarilla, A. A., Sng, J. D. J., Parry, R. H., Deerain, J. M., Potter, J. R., Setoh, Y. X., Rawle, D. J., Le, T. T., Modhiran, N., Wang, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23779-5 · Cited by 159
Mayaro Virus Pathogenesis and Transmission Mechanisms
Diagne, C. T., Bengue, M., Choumet, V., Hamel, R., Pompon, J., & Missé, D. (2020) · Pathogens · doi:10.3390/pathogens9090738 · Cited by 137
Lrp1 is a host entry factor for Rift Valley fever virus
Ganaie, S. S., Schwarz, M. M., McMillen, C. M., Price, D. A., Feng, A., Albe, J. R., Wang, W., Miersch, S., Orvedahl, A., Cole, A. R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.001 · Cited by 142
VLDLR and ApoER2 are receptors for multiple alphaviruses
Clark, L. E., Clark, S. A., Lin, C., Liu, J., Coscia, A., Smith, K. N., Yang, P., Neel, D. V., Lee, H., Brusic, V., et al. (2021) · Nature · doi:10.1038/s41586-021-04326-0 · Cited by 135
Tropism of the Chikungunya Virus
Matusali, G., Colavita, F., Bordi, L., Lalle, E., Ippolito, G., Capobianchi, M. R., & Castilletti, C. (2019) · Viruses · doi:10.3390/v11020175 · Cited by 122
Human Neonatal Fc Receptor Is the Cellular Uncoating Receptor for Enterovirus B
Zhao, X., Zhang, G., Liu, S., Chen, X., Peng, R., Dai, L., Qu, X., Li, S., Song, H., Gao, Z., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.035 · Cited by 123
A molecular understanding of alphavirus entry
Holmes, A. C., Basore, K., Fremont, D. H., & Diamond, M. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008876 · Cited by 126
Self-citationFHL1 is a major host factor for chikungunya virus infection
Meertens, L., Hafirassou, M. L., Couderc, T., Bonnet‐Madin, L., Kril, V., Kümmerer, B. M., Labeau, A., Brugier, A., Simon‐Lorière, E., Burlaud‐Gaillard, J., et al. (2019) · Nature · doi:10.1038/s41586-019-1578-4 · Cited by 100
Chikungunya virus and other emerging arthritogenic alphaviruses
de Souza, W. M., Lecuit, M., & Weaver, S. C. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01177-8 · Cited by 97
Cunha, M. S., Costa, P. A. G., Corrêa, I. A., de Souza, M. R. M., Calil, P. T., da Silva, G. P. D., Costa, S. M., Fonseca, V. W. P., & da Costa, L. J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01297 · Cited by 96
Pathophysiology of chikungunya virus infection associated with fatal outcomes
de Souza, W. M., Fumagalli, M. J., de Lima, S. T. S., Parise, P. L., Carvalho, D. C. M., Hernandez, C., de Jesus, R., Delafiori, J., Cândido, D. D. S., Carregari, V. C., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.02.011 · Cited by 96
Self-citationArthritogenic Alphaviruses: A Worldwide Emerging Threat?
Levi, L. I., & Vignuzzi, M. (2019) · Microorganisms · doi:10.3390/microorganisms7050133 · Cited by 88
Young, A. R., Locke, M. C., Cook, L. E., Hiller, B. E., Zhang, R., Hedberg, M. L., Monte, K. J., Novack, D. V., Diamond, M., & Lenschow, D. J. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007993 · Cited by 87
Self-citationA molecular understanding of alphavirus entry and antibody protection
Kim, A. S., & Diamond, M. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00825-7 · Cited by 87
Self-citationZhang, R., Earnest, J. T., Kim, A. S., Winkler, E. S., Desai, P., Adams, L. J., Hu, G., Bullock, C. B., Gold, B., Cherry, S. R., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.105 · Cited by 81
Self-citationNew Insights into Chikungunya Virus Infection and Pathogenesis
Kril, V., Aïqui-Reboul-Paviet, O., Briant, L., & Amara, A. (2021) · Annual Review of Virology · doi:10.1146/annurev-virology-091919-102021 · Cited by 81
Fox, J. M., Roy, V., Gunn, B. M., Huang, L., Edeling, M. A., Mack, M., Fremont, D. H., Doranz, B. J., Johnson, S., Alter, G., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aav5062 · Cited by 79
Self-citationPan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope
Kim, A. S., Kafai, N. M., Winkler, E. S., Gilliland, T. C., Cottle, E. L., Earnest, J. T., Jethva, P. N., Kapłonek, P., Shah, A. P., Fong, R. H., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.006 · Cited by 79
Self-citationSchrauf, S., Tschismarov, R., Tauber, E., & Ramsauer, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00592 · Cited by 84
Pathogenicity and virulence of chikungunya virus
Freppel, W., Silva, L. A., Stapleford, K. A., & Herrero, L. J. (2024) · Virulence · doi:10.1080/21505594.2024.2396484 · Cited by 71
Cellular Attachment and Entry Factors for Chikungunya Virus
Schnierle, B. S. (2019) · Viruses · doi:10.3390/v11111078 · Cited by 68
Quiroz, J. A., Malonis, R. J., Thackray, L. B., Cohen, C. A., Pallesen, J., Jangra, R. K., Brown, R. S., Hofmann, D., Holtsberg, F. W., Shulenin, S., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008061 · Cited by 69
Self-citationChikungunya and arthritis: An overview
Kumar, R., Ahmed, S., Parray, H. A., & Das, S. (2021) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2021.102168 · Cited by 72
Structural basis of Chikungunya virus inhibition by monoclonal antibodies
Zhou, Q. F., Fox, J. M., Earnest, J. T., Ng, T., Kim, A. S., Fibriansah, G., Kostyuchenko, V. A., Shi, J. R., Shu, B., Diamond, M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008051117 · Cited by 65
Self-citationHasan, S. S., Sun, C., Kim, A. S., Watanabe, Y., Chen, C.-L., Klose, T., Buda, G., Crispin, M., Diamond, M., Klimstra, W. B., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.067 · Cited by 65
Self-citationPowell, L. A., Miller, A. S., Fox, J. M., Kose, N., Klose, T., Kim, A. S., Bombardi, R. G., Tennekoon, R. N., Silva, A. D. D., Carnahan, R. H., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.07.008 · Cited by 68
Self-citationLDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus
Xu, Z., Du, W.-T., Wang, S., Wang, M., Yang, Y., Li, Y.-H., Li, Z., Zhao, L., Yang, Y., Luo, W., et al. (2024) · Cell Research · doi:10.1038/s41422-023-00917-w · Cited by 67
Structure of Venezuelan equine encephalitis virus with its receptor LDLRAD3
Ma, B., Huang, C., Ma, J., Xiang, Y., & Zhang, X. (2021) · Nature · doi:10.1038/s41586-021-03909-1 · Cited by 61
Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor
Basore, K., Ma, H., Kafai, N. M., Mackin, S., Kim, A. S., Nelson, C. A., Diamond, M., & Fremont, D. H. (2021) · Nature · doi:10.1038/s41586-021-03963-9 · Cited by 59
Self-citationSingle-cell RNA sequencing of human femoral head in vivo
Qiu, X., Liu, Y., Shen, H., Wang, Z., Gong, Y., Yang, J., Li, X., Zhang, H., Chen, Y., Zhou, C., et al. (2021) · Aging · doi:10.18632/aging.203124 · Cited by 58
Chikungunya virus replication in skeletal muscle cells is required for disease development
Lentscher, A. J., McCarthy, M. K., May, N. A., Davenport, B., Montgomery, S. A., Raghunathan, K., McAllister, N., Silva, L. A., Morrison, T. E., & Dermody, T. S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129893 · Cited by 57
Song, Y., Huang, H., Hu, Y., Zhang, J., Li, F., Yin, X., Shi, J., Li, Y., Li, C., Zhao, D., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010141 · Cited by 57
Xu, Z., Chen, X., Song, L., Fang, Y., & Yan, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.834595 · Cited by 57
Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus
Duvergé, A., & Negroni, M. (2020) · Viruses · doi:10.3390/v12111311 · Cited by 65
The Phosphatidylserine Receptor TIM-1 Enhances Authentic Chikungunya Virus Cell Entry
Kirui, J., Abidine, Y., Lenman, A., Islam, K., Gwon, Y.-D., Laßwitz, L., Evander, M., Bally, M., & Gerold, G. (2021) · Cells · doi:10.3390/cells10071828 · Cited by 55
Structure of Semliki Forest virus in complex with its receptor VLDLR
Cao, D., Ma, B., Cao, Z., Zhang, X., & Xiang, Y. (2023) · Cell · doi:10.1016/j.cell.2023.03.032 · Cited by 55
Overview on Chikungunya Virus Infection: From Epidemiology to State-of-the-Art Experimental Models
Constant, L. E. C., Rajsfus, B. F., Carneiro, P. H., Sisnande, T., Mohana‐Borges, R., & Allonso, D. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.744164 · Cited by 59
Teng, M., Yao, Y., Nair, V., & Luo, J. (2021) · Viruses · doi:10.3390/v13050779 · Cited by 56
Kim, A. S., Austin, S. K., Gardner, C. L., Zuiani, A., Reed, D. S., Trobaugh, D. W., Sun, C., Basore, K., Williamson, L. E., Crowe, J. E., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0286-4 · Cited by 54
Self-citationSong, D., Jia, X., Liu, X., Hu, L., Lin, K., Xiao, T., Qiao, Y., Zhang, J., Jia, D., Wong, C.-W., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00921-3 · Cited by 53
Filho, H. V. R., Coimbra, L. D., Cassago, A., Rocha, R. D. P. F., Guerra, J. V. D. S., de Felício, R., Carnielli, C. M., Leme, L., Padilha, A. C. M., Leme, A. F. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23400-9 · Cited by 53
Tan, Y. B., Lello, L. S., Liu, X., Law, Y.-S., Kang, C., Lescar, J., Zheng, J., Merits, A., & Luo, D. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1302 · Cited by 52
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress
Williamson, L. E., Reeder, K. M., Bailey, K. W., Tran, M. H., Roy, V., Fouch, M. E., Kose, N., Trivette, A., Nargi, R. S., Winkler, E. S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.033 · Cited by 51
Self-citationEntry receptors — the gateway to alphavirus infection
Zimmerman, O., Holmes, A. C., Kafai, N. M., Adams, L. J., & Diamond, M. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165307 · Cited by 49
Self-citationLuo, L., Wang, S., Zhu, L., Fan, B., Liu, T., Wang, L., Zhao, P., Dang, Y., Pei, S., Chen, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49838-y · Cited by 49
LDLR is used as a cell entry receptor by multiple alphaviruses
Zhai, X., Li, X., Veit, M., Wang, N., Wang, Y., Merits, A., Jiang, Z., Qin, Y., Zhang, X., Qi, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44872-5 · Cited by 47
Kim, A. S., Zimmerman, O., Fox, J. M., Nelson, C. A., Basore, K., Zhang, R., Durnell, L. A., Desai, C., Bullock, C. B., Deem, S. L., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.01.008 · Cited by 48
Self-citationZhao, J., Dellicour, S., Yan, Z., Veit, M., Gill, M. S., He, W., Zhai, X., Ji, X., Suchard, M. A., Lemey, P., et al. (2022) · Journal of Virology · doi:10.1128/jvi.01091-22 · Cited by 46
McAllister, N., Liu, Y., Silva, L. M., Lentscher, A. J., Chai, W., Wu, N., Griswold, K. A., Raghunathan, K., Vang, L., Alexander, J., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01500-20 · Cited by 45
Self-citationOrigin, genetic diversity, adaptive evolution and transmission dynamics of Getah virus
Shi, N., Zhu, X., Qiu, X., Cao, X., Jiang, Z., Lu, H., & Jin, N. (2021) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14395 · Cited by 43
Caluwé, L. D., Coppens, S., Vereecken, K., Daled, S., Dhaenens, M., Ostade, X. V., Deforce, D. L. D., Ariën, K. K., & Bartholomeeusen, K. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.615165 · Cited by 42
The life cycle of the alphaviruses: From an antiviral perspective
Skidmore, A. M., & Bradfute, S. B. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105476 · Cited by 42
Revisiting an old friend: new findings in alphavirus structure and assembly
Button, J. M., Qazi, S., Wang, J. C., & Mukhopadhyay, S. (2020) · Current Opinion in Virology · doi:10.1016/j.coviro.2020.06.005 · Cited by 44
Distinct Cellular Tropism and Immune Responses to Alphavirus Infection
Kafai, N. M., Diamond, M., & Fox, J. M. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101220-014952 · Cited by 42
Self-citationVertebrate-class-specific binding modes of the alphavirus receptor MXRA8
Zimmerman, O., Zimmerman, M. I., Raju, S., Nelson, C. A., Errico, J. M., Madden, E. A., Holmes, A. C., Hassan, A. O., VanBlargan, L. A., Kim, A. S., et al. (2023) · Cell · doi:10.1016/j.cell.2023.09.007 · Cited by 41
Self-citationThe low-density lipoprotein receptor promotes infection of multiple encephalitic alphaviruses
Ma, H., Adams, L. J., Raju, S., Sariol, A., Kafai, N. M., Jáňová, H., Klimstra, W. B., Fremont, D. H., & Diamond, M. (2024) · Nature Communications · doi:10.1038/s41467-023-44624-x · Cited by 43
Self-citationAlbulescu, I. C., Scholten, L., Taş, A., Hoornweg, T. E., Ferla, S., Kovacikova, K., Smit, J. M., Brancale, A., Snijder, E. J., & van Hemert, M. J. (2020) · Viruses · doi:10.3390/v12030314 · Cited by 41
Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus Infection
Williamson, L. E., Gilliland, T. H., Yadav, P. K., Binshtein, E., Bombardi, R. G., Kose, N., Nargi, R. S., Sutton, R. E., Durie, C. L., Armstrong, E., et al. (2020) · Cell · doi:10.1016/j.cell.2020.11.011 · Cited by 42
Self-citationAntiviral Functions of Monoclonal Antibodies against Chikungunya Virus
Jin, J., & Simmons, G. (2019) · Viruses · doi:10.3390/v11040305 · Cited by 40
Li, Q., Zhang, F., Lu, Y., Hu, H., Wang, J., Guo, C., Deng, Q., Liao, C., Wu, Q., Hu, T., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01417-6 · Cited by 39
TMEFF1 is a neuron-specific restriction factor for herpes simplex virus
Dai, Y., Idorn, M., Serrero, M. C., Pan, X., Thomsen, E. A., Narita, R., Maimaitili, M., Qian, X., Iversen, M. B., Reinert, L. S., et al. (2024) · Nature · doi:10.1038/s41586-024-07670-z · Cited by 38
The evolutionary and molecular history of a chikungunya virus outbreak lineage
Krambrich, J., Mihalič, F., Gaunt, M. W., Bohlin, J., Hesson, J. C., Lundkvist, Å., de Lamballerie, X. N., Li, C., Shi, W., & Pettersson, J. H. ‐. (2024) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012349 · Cited by 37
Keeler, S. P., & Fox, J. M. (2021) · Viruses · doi:10.3390/v13061037 · Cited by 38
Self-citationPersistent Joint Pain Following Arthropod Virus Infections
Suchowiecki, K., Reid, S. P., Simon, G. L., Firestein, G. S., & Chang, A. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-00987-y · Cited by 37
Shifts in receptors during submergence of an encephalitic arbovirus
Li, W., Plante, J. A., Lin, C., Basu, H., Plung, J. S., Fan, X., Boeckers, J. M., Oros, J., Buck, T. K., Anekal, P. V., et al. (2024) · Nature · doi:10.1038/s41586-024-07740-2 · Cited by 36
CEACAMs serve as toxin-stimulated receptors for enterotoxigenic Escherichia coli
Sheikh, A., Tumala, B., Vickers, T. J., Alvarado, D. M., Ciorba, M. A., Bhuiyan, T. R., Qadri, F., Singer, B. B., & Fleckenstein, J. M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012480117 · Cited by 36
Cryo-EM structure of eastern equine encephalitis virus in complex with heparan sulfate analogues
Chen, C.-L., Hasan, S. S., Klose, T., Sun, Y., Buda, G., Sun, C., Klimstra, W. B., & Rossmann, M. G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910670117 · Cited by 35
Self-citationChikungunya Vaccine Candidates: Current Landscape and Future Prospects
Schmidt, C., & Schnierle, B. S. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s366112 · Cited by 35
Structural and functional basis of VLDLR usage by Eastern equine encephalitis virus
Adams, L. J., Raju, S., Ma, H., Gilliland, T. H., Reed, D. S., Klimstra, W. B., Fremont, D. H., & Diamond, M. (2024) · Cell · doi:10.1016/j.cell.2023.11.031 · Cited by 34
Self-citationRangel, M. V., McAllister, N., Dancel-Manning, K., Noval, M. G., Silva, L. A., & Stapleford, K. A. (2021) · Journal of Virology · doi:10.1128/jvi.01586-21 · Cited by 34
Hakim, M. S., & Aman, A. T. (2022) · Viruses · doi:10.3390/v15010048 · Cited by 35
Vaccine elicitation and structural basis for antibody protection against alphaviruses
Sutton, M. S., Pletnev, S. V., Callahan, V., Ko, S., Tsybovsky, Y., Bylund, T., Casner, R. G., Cerutti, G., Gardner, C. L., Guirguis, V., et al. (2023) · Cell · doi:10.1016/j.cell.2023.05.019 · Cited by 33
Self-citationSahoo, B., & Chowdary, T. K. (2019) · Bioscience Reports · doi:10.1042/bsr20191077 · Cited by 33
Noval, M. G., Rodriguez-Rodriguez, B. A., Rangel, M. V., & Stapleford, K. A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.022 · Cited by 33
Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies
Andreana, I., Repellin, M., Carton, F., Kryza, D., Briançon, S., Chazaud, B., Mounier, R., Arpicco, S., Malatesta, M., Stella, B., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020278 · Cited by 34
Ross River Virus Infection: A Cross-Disciplinary Review with a Veterinary Perspective
Yuen, K. Y., & Bielefeldt‐Ohmann, H. (2021) · Pathogens · doi:10.3390/pathogens10030357 · Cited by 32
The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies
Earnest, J. T., Holmes, A. C., Basore, K., Mack, M., Fremont, D. H., & Diamond, M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108962 · Cited by 32
Self-citationCarpentier, K. S., Sheridan, R. M., Lucas, C. J., Davenport, B., Li, F. S., Lucas, E. D., McCarthy, M. K., Reynoso, G. V., May, N. A., Tamburini, B. A. J., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108966 · Cited by 33
Antiviral Strategies against Arthritogenic Alphaviruses
Abdelnabi, R., & Delang, L. (2020) · Microorganisms · doi:10.3390/microorganisms8091365 · Cited by 31
Yin, P., Davenport, B., Wan, J. J., Kim, A. S., Diamond, M., Ware, B. C., Tong, K., Couderc, T., Lecuit, M., Lai, J. R., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01449-0 · Cited by 32
Self-citationAn update on antiviral antibody-based biopharmaceuticals
Ahangarzadeh, S., Payandeh, Z., Arezumand, R., Shahzamani, K., Yarian, F., & Alibakhshi, A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106760 · Cited by 30
Mahish, C., De, S., Chatterjee, S., Ghosh, S., Keshry, S. S., Mukherjee, T., Khamaru, S., Tung, K. S., Subudhi, B. B., Chattopadhyay, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139808 · Cited by 30
Alphavirus-Induced Membrane Rearrangements during Replication, Assembly, and Budding
Masri, Z. E., Nasal, B. L., & Jose, J. (2021) · Pathogens · doi:10.3390/pathogens10080984 · Cited by 29
The RNA helicase DDX39A binds a conserved structure in chikungunya virus RNA to control infection
Tapescu, I., Taschuk, F., Pokharel, S. M., Zginnyk, O., Ferretti, M., Bailer, P., Whig, K., Madden, E. A., Heise, M. T., Schultz, D., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.10.008 · Cited by 29
On the Host Side of the Hepatitis E Virus Life Cycle
Oechslin, N., Moradpour, D., & Gouttenoire, J. (2020) · Cells · doi:10.3390/cells9051294 · Cited by 29
Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge
Kafai, N. M., Williamson, L. E., Binshtein, E., Sukupolvi-Petty, S., Gardner, C. L., Liu, J., Mackin, S., Kim, A. S., Kose, N., Carnahan, R. H., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20212532 · Cited by 28
Self-citationAdvances in high-throughput methods for the identification of virus receptors
Barrass, S. V., & Butcher, S. J. (2019) · Medical Microbiology and Immunology · doi:10.1007/s00430-019-00653-2 · Cited by 30
Izumida, M., Hayashi, H., Tanaka, A., & Kubo, Y. (2020) · Viruses · doi:10.3390/v12070722 · Cited by 28
Franz, S., Zillinger, T., Pott, F., Schüler, C., Dapa, S., Fischer, C., Passos, V., Stenzel, S., Chen, F., Döhner, K., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000909 · Cited by 29
Pott, F., Postmus, D., Brown, R. J. P., Wyler, E., Neumann, E., Landthaler, M., & Goffinet, C. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.2000891 · Cited by 32
Thamamongood, T., Aebischer, A., Wagner, V., Chang, M. W., Elling, R., Benner, C. W., García‐Sastre, A., Kochs, G., Beer, M., & Schwemmle, M. (2020) · Journal of Virology · doi:10.1128/jvi.00752-20 · Cited by 28
Antiviral drug discovery against arthritogenic alphaviruses: Tools and molecular targets
Abdelnabi, R., Jacobs, S., Delang, L., & Neyts, J. H. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113777 · Cited by 27
Arboviruses and Muscle Disorders: From Disease to Cell Biology
Filippone, C., Legros, V., Jeannin, P., Choumet, V., Butler-Browne, G. S., Zoladek, J., Mouly, V., Antoine Gessain, A., & Ceccaldi, P. (2020) · Viruses · doi:10.3390/v12060616 · Cited by 27
Metadata
- Authors
- Zhang, R., Kim, A. S., Fox, J. M., Nair, S., Basore, K., Klimstra, W. B., Rimkunas, R., Fong, R. H., Lin, H., Poddar, S., Crowe, J. E., Doranz, B. J., Fremont, D. H., & Diamond, M. S.
- Affiliations
- Washington University in St. Louis (US)
- University of Pittsburgh (US)
- Integral Molecular (United States) (US)
- Vanderbilt University Medical Center (US)
- Corresponding author
- Diamond, Michael S.
- ORCID
- Venue
- Nature
- Published
- 2018-05
- Volume
- 557
- Issue
- 7706
- Pages
- 570-574
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5970976
- OpenAlex
- W2803841447
- Cited by
- 448
- References
- 41
- Citations by year
- 2026: 60 · 2025: 61 · 2024: 58 · 2023: 54 · 2022: 64 · 2021: 62 · 2020: 47 · 2019: 35 · 2018: 6
- FWCI
- 38.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI114816, R01AI123348, R01AI095436)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- MXRA8, arthritogenic alphaviruses, chikungunya virus, Ross River virus, Mayaro virus, O'nyong-nyong virus, viral entry, adhesion molecules, foot swelling, synovial fibroblasts, CRISPR-Cas9 screen
- MeSH terms
- Animals, Chikungunya virus, Fibroblasts, Humans, Immunoglobulins, Male, Membrane Proteins, Osteoblasts, Receptors, Fc, Receptors, Virus, 3T3 Cells, Muscle, Skeletal, Antibodies, Blocking, Chondrocytes, Mice, CRISPR-Cas Systems, O'nyong-nyong Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review